Zura Bio Statistics
Total Valuation
Zura Bio has a market cap or net worth of $502.87 million. The enterprise value is $393.46 million.
Important Dates
The next estimated earnings date is Thursday, May 14, 2026, before market open.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Zura Bio has 94.88 million shares outstanding. The number of shares has increased by 25.43% in one year.
| Current Share Class | 94.88M |
| Shares Outstanding | 94.88M |
| Shares Change (YoY) | +25.43% |
| Shares Change (QoQ) | +0.27% |
| Owned by Insiders (%) | 11.64% |
| Owned by Institutions (%) | 36.74% |
| Float | 54.74M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 3.85 |
| P/TBV Ratio | 4.95 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.05
| Current Ratio | 9.05 |
| Quick Ratio | 8.82 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -52.49% and return on invested capital (ROIC) is -35.96%.
| Return on Equity (ROE) | -52.49% |
| Return on Assets (ROA) | -32.05% |
| Return on Invested Capital (ROIC) | -35.96% |
| Return on Capital Employed (ROCE) | -74.11% |
| Weighted Average Cost of Capital (WACC) | 5.59% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.48M |
| Employee Count | 40 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +286.86% in the last 52 weeks. The beta is 0.24, so Zura Bio's price volatility has been lower than the market average.
| Beta (5Y) | 0.24 |
| 52-Week Price Change | +286.86% |
| 50-Day Moving Average | 6.08 |
| 200-Day Moving Average | 4.17 |
| Relative Strength Index (RSI) | 40.18 |
| Average Volume (20 Days) | 628,194 |
Short Selling Information
The latest short interest is 6.15 million, so 6.49% of the outstanding shares have been sold short.
| Short Interest | 6.15M |
| Short Previous Month | 5.75M |
| Short % of Shares Out | 6.49% |
| Short % of Float | 11.24% |
| Short Ratio (days to cover) | 9.75 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -75.25M |
| Pretax Income | -68.65M |
| Net Income | -99.35M |
| EBITDA | -75.20M |
| EBIT | -75.25M |
| Earnings Per Share (EPS) | -$1.06 |
Full Income StatementBalance Sheet
The company has $109.41 million in cash and n/a in debt, giving a net cash position of $109.41 million or $1.15 per share.
| Cash & Cash Equivalents | 109.41M |
| Total Debt | n/a |
| Net Cash | 109.41M |
| Net Cash Per Share | $1.15 |
| Equity (Book Value) | 101.54M |
| Book Value Per Share | 1.38 |
| Working Capital | 99.90M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$64.82 million and capital expenditures -$113,000, giving a free cash flow of -$64.93 million.
| Operating Cash Flow | -64.82M |
| Capital Expenditures | -113,000 |
| Depreciation & Amortization | 49,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -64.93M |
| FCF Per Share | -$0.68 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |